ClinicalTrials.Veeva

Menu

Impact of Tactile Kinesthetic Stimulation and Soft Tissue Manipulation on Cortisol in Preterm

F

faizan kashoo, PT

Status and phase

Not yet enrolling
Phase 1

Conditions

Neonatal Disorder

Treatments

Other: Standard Therapy
Other: Tactile-Kinesthetic Stimulation (TKS) and Soft Tissue Manipulation (STM)

Study type

Interventional

Funder types

Other

Identifiers

NCT06845137
SEC/SAHS/PHD/24/09

Details and patient eligibility

About

Effect of Soft tissue Therapy in managing Procedural Pain among neonates admitted to the neonatal intensive care unit. This study focuses on procedural pain management with the help of Soft tissue manipulation, which includes various techniques like stroking and petrissage manipulations.

Full description

Preterm neonates are highly vulnerable to stress due to their immature physiological systems and exposure to intensive medical treatments. Elevated blood cortisol levels, a key indicator of stress, have been linked to negative neurodevelopmental and physiological outcomes. Tactile-Kinesthetic Stimulation (TKS) and Soft Tissue Manipulation (STM) are non-invasive therapeutic approaches that may help alleviate stress and support overall development in preterm infants. TKS and STM were chosen for their proven benefits in promoting neurodevelopment, stress reduction, and physiological stability in preterm neonates. Unlike pharmacological interventions, these non-invasive therapies enhance blood circulation, regulate cortisol levels, and improve autonomic function, fostering growth and early adaptation to extrauterine life without adverse effects. This prospective experimental study aims to assess the impact of TKS and STM on blood cortisol levels and pain in preterm neonates admitted to pediatric care units. The intervention group will receive TKS and STM. TKS includes passive range of motion for upper and lower limbs whereas STM includes effleurage/stroking, petrissage, frictional and percussive manipulations daily for 24 minutes over four consecutive days, while the control group will receive standard neonatal care without additional interventions. Blood samples for cortisol measurement will be collected on days 1 and 4. Secondary outcomes will include physiological parameters such as heart rate, oxygen saturation, and weight gain. Statistical analyses will compare baseline and post-intervention cortisol levels within and between groups. Trained staff nurse will measure blood cortisol using ELISA. Participants, statisticians, and outcome assessors remain blinded. ELISA ensures high reliability (intra-assay CV <10%) and validity (correlates strongly with gold-standard mass spectrometry). Blood cortisol levels in preterm neonates can be influenced by factors like gestational age, birth weight, medical interventions, pain, stress, feeding patterns, and NICU environment. To control variability, standardized stimulation protocols, consistent feeding schedules, minimal handling outside interventions and controlled ambient conditions (light, noise, temperature) were maintained, ensuring that observed cortisol changes were primarily due to the intervention We anticipate that preterm neonates receiving TKS and STM will exhibit a significant reduction in blood cortisol levels and pain compared to those in the control group, along with improvements in secondary outcomes. This study aims to generate evidence supporting the efficacy of TKS and STM in reducing stress biomarkers, ultimately promoting their integration into neonatal care protocols to enhance the developmental outcomes of preterm infants

Enrollment

60 estimated patients

Sex

All

Ages

Under 28 days old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Underwent medical procedures associated with procedural pain, such as venipuncture, heel pricks, or tracheal intubation.
  2. Preterm neonates (28 to 36 weeks of gestation)
  3. Stable Neonates

Exclusion criteria

  1. Post-Surgical/operative cases
  2. Infants with neurological conditions such as siezures etc.
  3. Neonates/infants with congenital anomalies.
  4. Neonates with extremely low birth weight

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Parallel Assignment

Masking

Quadruple Blind

60 participants in 2 patient groups

Experimental Group
Experimental group
Description:
In this study, preterm neonates in the experimental group received TKS and STM as part of their intervention. TKS involved the passive range of motion exercises for the neonates' joints, aiming to enhance mobility and stimulate neuromuscular responses. STM, on the other hand, incorporated various techniques such as gentle stroking, petrissage, and percussion, all of which were designed to improve circulation and facilitate pain management. Stroking techniques provided a soothing effect, while petrissage-through kneading and compression-helped in muscle relaxation and circulation enhancement. Percussion techniques further contributed to muscle stimulation and fluid movement, ultimately supporting physiological stability. These interventions promoted venous return to the heart, cleared lactic acid buildup, and facilitated increased oxygen delivery to tissues. The improved blood flow also triggered endorphin release, serving as a natural pain reliever, thereby reducing discomfort and enh
Treatment:
Other: Tactile-Kinesthetic Stimulation (TKS) and Soft Tissue Manipulation (STM)
Standard Treatment
Active Comparator group
Description:
The Neonate will receive all the nursing care plan as described in experimental except tactile and massage from the therapist.
Treatment:
Other: Standard Therapy

Trial contacts and locations

1

Loading...

Central trial contact

Aksh Professor, PhD; Abhishek Chahal Sharma, MPT

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems